Related Experiment Video
Updated: Dec 6, 2025
Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
Pharmacokinetic Principles and Their Application to Central Nervous System Tumors
Joelle P Straehla1,2, Katherine E Warren1
1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA 02115, USA.
Abstract:
Despite increasing knowledge of the biologic drivers of central nervous system tumors, most targeted agents trialed to date have not shown activity against these tumors in clinical trials. To effectively treat central nervous system tumors, an active drug must achieve and maintain an effective exposure at the tumor site for a long enough period of time to exert its intended effect. However, this is difficult to assess and achieve due to the constraints of drug delivery to the central nervous system. To address this complex problem, an understanding of pharmacokinetic principles is necessary. Pharmacokinetics is classically described as the quantitative study of drug absorption, distribution, metabolism, and elimination. The innate chemical properties of a drug, its administration (dose, route and schedule), and host factors all influence these four key pharmacokinetic phases. The central nervous system adds a level of complexity to standard plasma pharmacokinetics as it is a coupled drug compartment. This review will discuss special considerations of pharmacokinetics in the context of therapeutic development for central nervous system tumors.
Insights
Understanding drug pharmacokinetics is crucial for developing effective central nervous system tumor therapies. This review highlights key pharmacokinetic challenges and considerations for brain tumor drug development.
Area of Science:
- Neuro-oncology
- Pharmacology
- Drug Development
Background:
- Despite advances in understanding brain tumor biology, targeted therapies often fail in clinical trials.
- Effective treatment requires sustained drug exposure at the tumor site, which is challenging due to drug delivery limitations to the central nervous system.
Purpose of the Study:
- To review the pharmacokinetic principles essential for developing effective central nervous system (CNS) tumor therapeutics.
- To discuss the unique pharmacokinetic challenges associated with drug delivery to the brain.
Main Methods:
- Literature review of pharmacokinetic principles and their application to CNS drug development.
- Discussion of factors influencing drug absorption, distribution, metabolism, and elimination within the CNS.
Main Results:
- Standard plasma pharmacokinetics are complicated by the unique, coupled nature of the CNS drug compartment.
- Drug properties, administration routes, and host factors significantly impact CNS drug exposure.
Conclusions:
- A thorough understanding of pharmacokinetics is necessary to overcome drug delivery barriers in the central nervous system.
- Addressing these pharmacokinetic considerations is vital for successful therapeutic development against brain tumors.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:27Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
01:21Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:23Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
01:30Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...